查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197531

医疗植入物市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Medical Implants Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内 (2022-2027)，医疗植入物市场预计将以 7.35% 的复合年增长率增长。

由于供应链限制和患者就诊次数减少，COVID-19 最初对医疗植入物市场的增长产生了重大影响。 例如，根据 2021 年 9 月在患者安全杂誌上发表的题为“COVID-19 对医疗器械报告和调查的影响”的研究，由于人与人之间接触类型的限制，患者可能接受的治疗是有限的，大流行使医疗植入物的研究更具挑战性。 此类研究表明，COVID-19 对市场增长产生了重大影响。

促进医疗植入物市场增长的主要因素是老年人口的增加、慢性病的负担、对美容牙科的需求增加以及医疗植入物的技术进步。

由于全球人口迅速老龄化，骨科和心血管疾病的负担随着年龄的增长而增加，这就产生了对医疗植入物的需求，推动了市场增长。 例如，根据世界卫生组织 (WHO) 的数据，2021 年 10 月，全球 60 岁及以上人口将占 2050 年世界人口的 22%。 此外，同一份文件估计，到 2050 年，世界上 80% 的老年人将生活在低收入和中等收入国家。 人们发现人口老龄化会增加疾病的数量，这反过来又有助于推动全球对医疗植入物的需求。

此外，预计整容手术的增加也将在预测期内推动医疗植入物市场的增长。 例如，根据国际美容整形外科学会2020年发布的一份报告，隆胸手术位居美容手术前列，2020年进行了1,624,281例手术。 此外，根据世界卫生组织（WHO）于2020年3月发布的最新资料，估计全球约有35亿人患有口腔疾病，以及可能导致牙齿脱落的严重牙周（牙龈）疾病。也很常见，据说影响了世界上近 10% 的人口。 因此，整容手术的兴起增加了对乳房和牙科植入物的需求，推动了市场增长。 在加速医疗植入物市场发展方面发挥关键作用的其他一些因素包括人口可支配收入的增加、植入物领域的技术进步、更容易获得医疗设施，以及各种事故导致肢体和器官受伤的病例增加.

然而，医疗植入物的高成本和严格的监管政策预计将在预测期内抑制市场。

医疗植入物市场趋势

在医疗植入物市场中，骨科植入物部分有望占据较大的市场份额

在医疗植入物市场中，骨科植入物部分预计将占据很大的市场份额。 骨科植入物是用于替换缺失的关节和骨骼或支撑受损骨骼的医疗植入设备。 这些设备使用钛合金和不銹钢製造以增加强度，塑料涂层充当人造软骨。 内固定是一种骨科手术，其中放置植入物以修復受损的骨骼。 它还可以矫正畸形，稳定姿势，恢復骨骼功能。

此外，随着 COVID-19 大流行给医疗保健系统带来压力，骨科手术的数量正在减少，从而限制了对医疗植入物的需求。 然而，预计未来几年大流行后的需求将会增加。 此外，骨科植入物正在见证从传统外科手术到现代固定和修復装置的转变。 由于老年人患骨质疏鬆症、骨关节炎和其他肌肉骨骼疾病的风险增加，对骨科植入物的需求显着增加。

在2021年4月发表的一篇题为“骨折骨科植入物的微观结构分析”的论文中，不銹钢和钛合金由于其优异的生物相容性、耐腐蚀性和耐用性，被认为被广泛用作外科植入物植入材料。 他们还报告说，这些材料具有相对较高的电阻，使其适合製造生物医学部件。

此外，主要市场参与者越来越多地推出骨科植入物，预计也将推动这一细分市场的增长。 例如，2021 年 8 月，骨科植入物公司宣布了其经 FDA 批准的腕部骨折电镀技术 DRPx 系统，以帮助门诊手术中心 (ASC) 和医院提高财务可持续性。现已开始销售。 2020年10月，美国美敦力推出了Adaptix Interbody System，这是一款采用Titan nanoLOCK表面技术的可导航钛脊柱植入物。

因此，由于上述因素，预计该细分市场将在预测期内增长。

北美将占据很大的市场份额，预计在预测期内也会如此

北美目前在全球医疗植入物市场中占有很大份额，预计在预测期内将遵循同样的趋势。 这是由于多种因素造成的，例如关节炎等疾病的发病率上升，该国因牙齿脱落而越来越多地采用美容牙科手术，完善的保险政策以及先进医疗基础设施的可用性。

例如，根据美国牙科协会 2020 年版的数据，超过 500 万年龄在 65 至 74 岁的美国人完全无牙，近 300 万无牙增加。 另一方面，掉牙主要是老年人的问题。 这是因为 91% 的 20-64 岁成年人患有蛀牙，而 27% 的人未经治疗。 此外，因蛀牙而导致牙齿脱落的案例也很多。 结果，牙齿逐渐鬆动并脱落。 因此，老年人牙齿脱落是牙齿疾病引起的常见问题，从而推动了老年人对种植牙的需求。

此外，向市场推出新植入物也推动了该地区的增长。 例如，2020 年 9 月，Ditron Dental USA 开始在美国开展其牙种植体产品组合的商业活动。 同样，2022 年 6 月，ZimVie Inc. 宣布美国食品和药物管理局批准了 T3 PRO 锥形种植体和编码紧急癒合基台。 T3 PRO 是 ZimVie 牙种植体系列的最新成员，它建立在 T3 锥形种植体成熟的解决方案之上。 同样，2022 年 2 月，专注于增强现实和患者特定解决方案的脊柱植入物公司 DeGen Medical, Inc. 宣布推出 Impulse AM，这是一种用于后骨间融合的 3D 打印多孔钛植入物。 因此，在美国越来越多地推出医疗植入物将导致采用率增加，从而推动该地区的市场增长。

综上所述，北美市场有望快速扩张。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 老龄化社会的到来和慢性病的增加
    • 对美容牙科的需求增加
    • 医疗植入物技术进步
  • 市场製约因素
    • 严格的监管改革
    • 医疗植入物的报销问题和高成本
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 骨科植入物
      • 髋关节骨科手术设备
      • 联合重建
      • 膝关节矫形器
      • 脊柱矫形器械
      • 其他产品
    • 心血管植入物
      • 起搏装置
      • 支架
      • 心臟结构植入物
    • 眼科植入物
      • 人工晶状体
      • 青光眼植入物
    • 种植牙
    • 面部植入物
    • 乳房植入物
    • 其他植入物
  • 按材料类型
    • 金属生物材料
    • 高分子生物材料
    • 天然生物材料
    • 陶瓷生物材料
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Abbott Laboratories
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Conmed Corporation
    • Globus Medical, Inc.
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Smith & Nephew PLC
    • Stryker Corporation
    • Zimmer Biomet
    • Straumann AG
    • Dentsply Sirona
    • Osstem Implant Co. Ltd
    • Henry Schein Inc.
    • Abbvie Inc.（Allergan PLC）
    • Ivoclar Vivadent Inc.
    • GC Aesthetics
    • 3M Company

第7章 市场机会与今后动向

简介目录
Product Code: 67164

The medical implants market is poised to grow at a CAGR of 7.35% during the forecast period (2022-2027).

COVID-19 had significantly impacted the medical implants market's growth initially due to supply chain restrictions and the reduced number of hospital visits by patients. For instance, according to the study published in Patient Safety, titled "The Impact of COVID-19 on Medical Device Reporting and Investigation" in September 2021, constraints on person-to-person contact limited the sort of treatment patients may receive, and the pandemic made researching medical implants more challenging. Such studies suggest that COVID-19 has significantly impacted the growth of the market.

The major factors contributing to the growth of the medical implants market are the increasing geriatric population, the burden of chronic diseases, increasing demand for cosmetic dentistry, and technological advancements in medical implants.

The global population is aging rapidly, so with increasing age, the burden of orthopedic and cardiovascular diseases is increasing, which creates a need for medical implants and thus drives the growth of the market. For instance, in October 2021, according to the World Health Organization (WHO), the world's population aged 60 and above will reach a share of 22% of the total world population in 2050. Furthermore, according to the same source, by 2050, 80% of the world's elderly will live in low and middle-income countries. This increase in the number of older adults is found to augment the number of disorders, which subsequently helps boost the demand for medical implants across the globe.

Furthermore, the rise in aesthetic surgeries is also expected to drive the growth of the medical implants market over the forecast period. For instance, according to the report published by the International Society of Aesthetic Plastic Surgery in 2020, breast augmentation was among the top aesthetic surgical procedures in 2020, with 1,624,281 surgeries. Moreover, according to a March 2020 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people worldwide, and severe periodontal (gum) disease, which may result in tooth loss, is also very common, with almost 10% of the global population affected. Thus, the increasing incidence of aesthetic surgeries is driving the need for breast and dental implants, thereby driving the market growth. A few other factors are playing pivotal roles in accelerating the medical implants market include the hike in disposable income among people, technological advancements in the field of implants, the availability of better medical facilities, and a growing number of cases involving damaged limbs or organs caused by various accidents.

However, the high cost of medical implants and stringent regulatory policies are expected to restrain the market for the forecast period.

Medical Implants Market Trends

Orthopedic Implants Segment is Expected to Hold a Significant Market Share in the Medical Implants Market

The orthopedic implants segment is expected to hold a significant market share in the medical implants market. Orthopedic implants are medical implant devices used to replace missing joints or bones or to support damaged bones. These devices are manufactured using titanium alloys and stainless steel for strength, while plastic coating acts as artificial cartilage. Internal fixation is a type of surgery in orthopedics involving implant implementation to repair the damaged bone. These implants also treat deformities, stabilize body posture, and restore normal skeletal function.

Furthermore, as the COVID-19 pandemic has burdened the healthcare system, there has been a decrease in the number of orthopedic surgeries performed, thereby restricting the demand for medical implants. However, demand is expected to increase post-pandemic over the coming years. Moreover, orthopedic implants have witnessed a shift from conventional surgical procedures to modern fixation and prosthetic devices. The demand for orthopedic implants has increased significantly because of the senior population's increased risk of osteoporosis, osteoarthritis, and other musculoskeletal disorders.

The article titled "Microstructural Analysis of Fractured Orthopedic Implants" published in April 2021 reported that stainless steel and titanium alloys are widely used as implant materials in orthopedic surgery due to their good biocompatibility, corrosion resistance, and durability. It also reported that these materials are suitable for the production of bio-components used in medicine due to their relatively high tolerance.

In addition, rising launches of orthopedic implants by key market players are also expected to drive the growth of this segment. For instance, in August 2021, the Orthopaedic Implant Company launched its wrist fracture plating technology, the DRPx System, which has received Food and Drug Administration approval to enable ambulatory surgical centers (ASCs) and hospitals to improve their financial sustainability. In October 2020, Medtronic in the United States launched the Adaptix Interbody System, a navigated titanium spine implant with Titan nanoLOCK surface technology.

Therefore, this segment is expected to grow over the forecast period due to the above factors.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North America currently holds a major share in the global medical implants market and is expected to follow the same trend throughout the forecast period. This is due to several factors, such as the rising incidence of diseases like arthritis, the rising adoption of cosmetic dental procedures due to tooth loss in the country, well-established insurance policies, and the availability of advanced healthcare infrastructure.

For instance, according to the American Dental Association 2020, more than 5 million United States seniors aged 65 to 74 have complete tooth loss, with nearly 3 million edentulous. Tooth loss, on the other hand, is primarily a problem for the elderly. This is because 91 percent of adults aged 20 to 64 have dental caries, with 27 percent going untreated. Furthermore, tooth decay is a common cause of tooth loss in many cases. As a result, teeth gradually loosen and fall out. Thus, the senior dental loss is a common problem due to dental diseases, thereby driving the demand for dental implants in the geriatric population. ​

Furthermore, the introduction of new implants into the market is also driving growth in the region. For instance, in September 2020, Ditron Dental USA launched its commercial operations in the United States for its dental implant portfolio. Likewise, in June 2022, ZimVie Inc. announced that the Food and Drug Administration-cleared T3 PRO Tapered Implant and Encode Emergence Healing Abutment in the United States. The T3 PRO is the newest addition to ZimVie's family of dental implants and builds on the proven solutions of the T3 Tapered Implant. Similarly, in February 2022, DeGen Medical, Inc., a spinal implant company specializing in augmented reality and patient-specific solutions, launched Impulse AM, a 3D-printed porous titanium implant for posterior interbody fusion. Therefore, the rise in the launch of medical implants in the United States will lead to increased adoption, thereby driving market growth in this region.

Hence, owing to the abovementioned factors, the North American market is expected to drive swiftly.

Medical Implants Market Competitor Analysis

The medical implants market is fragmented and consists of several major players. In terms of market share, a few major players dominate the market. Some prominent players are vigorously making acquisitions of other companies to consolidate their market positions globally. These major global medical implants market companies include Abbott Laboratories, 3M Company, Strauman AG, Dentsply Sirona, Johnson & Johnson Limited, Stryker, and Boston Scientific Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Burden of Chronic Diseases
    • 4.2.2 Increasing Demand for Cosmetic Dentistry
    • 4.2.3 Technological Advancements in the Medical Implants
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Reforms
    • 4.3.2 Reimbursement Issues and High Cost of Medical Implants
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Orthopedic Implants
      • 5.1.1.1 Hip Orthopaedic Device
      • 5.1.1.2 Joint Reconstruction
      • 5.1.1.3 Knee Orthopedic Devices
      • 5.1.1.4 Spine Orthopedic Devices
      • 5.1.1.5 Other Products
    • 5.1.2 Cardiovascular Implants
      • 5.1.2.1 Pacing devices
      • 5.1.2.2 Stents
      • 5.1.2.3 Structural Cardiac Implants
    • 5.1.3 Ophthalmic implants
      • 5.1.3.1 Intraocular lens
      • 5.1.3.2 Glaucoma Implants
    • 5.1.4 Dental Implants
    • 5.1.5 Facial Implants
    • 5.1.6 Breast Implants
    • 5.1.7 Other Implants
  • 5.2 By Type of Material
    • 5.2.1 Metallic Biomaterial
    • 5.2.2 Polymers Biomaterial
    • 5.2.3 Natural Biomaterial
    • 5.2.4 Ceramic Biomaterial
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Biotronik SE & Co. KG
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Cardinal Health, Inc.
    • 6.1.5 Conmed Corporation
    • 6.1.6 Globus Medical, Inc.
    • 6.1.7 Integra Lifesciences Holdings Corporation
    • 6.1.8 Johnson & Johnson
    • 6.1.9 Smith & Nephew PLC
    • 6.1.10 Stryker Corporation
    • 6.1.11 Zimmer Biomet
    • 6.1.12 Straumann AG
    • 6.1.13 Dentsply Sirona
    • 6.1.14 Osstem Implant Co. Ltd
    • 6.1.15 Henry Schein Inc.
    • 6.1.16 Abbvie Inc. (Allergan PLC)
    • 6.1.17 Ivoclar Vivadent Inc.
    • 6.1.18 GC Aesthetics
    • 6.1.19 3M Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS